Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Lopinavir/Ritonavir”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Early research (Phase 1)Study completedNCT00985543
What this trial is testing

Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.

Who this might be right for
Acquired Immunodeficiency Syndrome
Kirby Institute 22
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Post-approval studies (Phase 4)Study completedNCT02348177
What this trial is testing

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

Who this might be right for
Acquired Immunodeficiency SyndromeTuberculosis
Drugs for Neglected Diseases 96
Early research (Phase 1)Study completedNCT01660477
What this trial is testing

Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole

Who this might be right for
Pharmacokinetics of IsavuconazolePharmacokinetics of Lopinavir/RitonavirHealthy Volunteers
Astellas Pharma Global Development, Inc. 68
Early research (Phase 1)Study completedNCT00774735
What this trial is testing

GSK1349572 Drug Interaction Study With Protease Inhibitors

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 30
Not applicableStudy completedNCT00179335
What this trial is testing

Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults

Who this might be right for
HIV Infections
Albert Einstein College of Medicine 45
Early research (Phase 1)Study completedNCT00833378
What this trial is testing

Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.

Who this might be right for
Hepatitis C
GlaxoSmithKline 40
Testing effectiveness (Phase 2)Study completedNCT00125983
What this trial is testing

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 32
Testing effectiveness (Phase 2)Study completedNCT01139905
What this trial is testing

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

Who this might be right for
HIV-1 Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Early research (Phase 1)Study completedNCT00920088
What this trial is testing

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 24
Early research (Phase 1)Study completedNCT02159352
What this trial is testing

Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 49
Testing effectiveness (Phase 2)Study completedNCT01159275
What this trial is testing

Lopinavir (LPV) Dose Reduction

Who this might be right for
HIV-1 Infections
The HIV Netherlands Australia Thailand Research Collaboration 20
Testing effectiveness (Phase 2)Study completedNCT00887120
What this trial is testing

Dose Reduction of Lopinavir in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Not applicableStudy completedNCT00176033
What this trial is testing

Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra

Who this might be right for
HealthyPharmacokinetics
Heidelberg University 12
Early research (Phase 1)Study completedNCT01148004
What this trial is testing

The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

Who this might be right for
HIVFenofibrateProtease Inhibitors+2 more
National Institutes of Health Clinical Center (CC) 25
Post-approval studies (Phase 4)Study completedNCT00810108
What this trial is testing

Lopinavir/Ritonavir (Kaletra) PK in Children

Who this might be right for
HIV/AIDS TreatmentHIV Infections
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 12
Early research (Phase 1)Study completedNCT00766818
What this trial is testing

The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet

Who this might be right for
PregnancyHIV
University of North Carolina, Chapel Hill 12
Testing effectiveness (Phase 2)Study completedNCT01138202
What this trial is testing

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Testing effectiveness (Phase 2)Study completedNCT02415985
What this trial is testing

Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly

Who this might be right for
HIVTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Not applicableStudy completedNCT00474201
What this trial is testing

Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil

Who this might be right for
Healthy Volunteers
National Institutes of Health Clinical Center (CC) 15
Next Page